Pharma chiefs out to defend intellectual property at IFPMA briefing on vaccines ahead of WHO/CR ip pool proposal, exp tomorrow. $PFE's Bourla: "At this point in time it's nonsense, it's also dangerous," $GSK's Walmsley: "Not enormous evidence that IP is a barrier to access." Etc.